FRONTIER ORBITALS IN CHEMICAL AND BIOLOGICAL ACTIVITY: QUANTITATIVE RELATIONSHIPS AND MECHANISTIC IMPLICATIONS*

REFERENCES

• Fukui K. Recognition of stereochemical paths by orbital interaction. Acc. Chem. Res. 1971; 4: 57–64
   Web of Science ®Google Scholar
• Klopman G. A semi-empirical treatment of molecular structures II. Molecular terms and application to diatomic molecules. J. Am. Chem. Soc. 1964; 86: 4550–4557
   Web of Science ®Google Scholar
• Klopman G. Chemical reactivity and the concept of charge- and frontier-controlled reactions. J. Am. Chem. Soc. 1968; 90: 223–234
   Web of Science ®Google Scholar
• Klopman G., Hudson R. F. Polyelectronic perturbation treatment of chemical reactivity. Theoret. Chim. Acta 1967; 8: 165–174
   Google Scholar
• Hudson R. F., Klopman G. A general perturbation treatment of chemical reactivity. Tetraheadron Lett. 1967; 1103–1108
   Web of Science ®Google Scholar
• Salem L. Intermolecular orbital theory of the interaction between conjugated systems. I. General theory. J. Am. Chem. Soc. 1968; 90: 543–552, and 553–566
   Web of Science ®Google Scholar
• Fleming I. Frontier Orbitals and Organic Chemical Reactions. John Wiley & Sons, New York 1980
   Google Scholar
• Kier L. B. Molecular Orbital Theory in Drug Research. Academic Press, New York 1971
   Google Scholar
• Molecular Orbital Studies in Chemical Pharmacology, L. B. Kier. Springer-Verlag, New York 1970
   Google Scholar
• Simon Z. Quantum Biochemistry and Specific Interactions. Abacus, London 1976
   Google Scholar
• Lewis D. F. V. COMPACT and the importance of frontier orbitals in toxicity mediated by the cytochrome P450 mono-oxygenase system. Toxicol. Model. 1995; 1: 85–97
   Google Scholar
• Clark T. Handbook of Computational Chemistry. John Wiley & Sons, New York 1985
   Google Scholar
• Hirst D. M. A Computational Approach to Chemistry. Blackwell, Oxford 1990
   Google Scholar
• Warshel A. Computer Modeling of Chemical Reactions in Enzymes and Solutions. John Wiley & Sons, New York 1997
   Google Scholar
• Lewis D. F. V. MINDO/3: A review of the literature. Chem. Rev. 1986; 86: 1111–1123
   Web of Science ®Google Scholar
• Lewis D. F. V. MO-QSARs: A review of molecular orbital-generated quantitative structure–activity relationships. Prog. Drug Metab. 1990; 12: 205–255
   Google Scholar
• Kubinyi H. QSAR and 3D QSAR in drug design 1 and 2. Drug Discovery Today 1997; 2: 457–567, and 538–546
   Web of Science ®Google Scholar
• Atkins P. W., Friedman R. S. Molecular Quantum Mechanics. Oxford University Press, Oxford 1997
   Google Scholar
• Murrell J. N., Harget A. J. Semi-empirical Self-consistent-field Molecular Orbital Theory of Molecules. John Wiley & Sons, New York 1972
   Google Scholar
• Dewar M. J. S. Development and status of MINDO/3 and MNDO. J. Mol. Struct. 1983; 100: 41–50
   Web of Science ®Google Scholar
• Dewar M. J. S., Dougherty R. C. The PMO Theory of Organic Chemistry. Plenum, New York 1975
   Google Scholar
• Dewar M. J. S., Storch D. M. Comparative tests of theoretical procedures for studying chemical reactions. J. Am. Chem. Soc. 1985; 107: 3898–3902
   Web of Science ®Google Scholar
• Pople J. A., Beveridge D. L. Approximate Molecular Orbital Theory. McGraw–Hill, New York 1970
   Google Scholar
• Richards W. G. Quantum Pharmacology. Butterworths, London 1983
   Google Scholar
• Segal G. A. Semi-empirical Methods of Electronic Structure Calculation. Plenum, New York 1977
   Google Scholar
• McWeeney R. Coulon's Valence. Oxford University Press, Oxford 1979
   Google Scholar
• Pople J. A., Santry D. P., Segal G. A. Approximate self-consistent molecular orbital theory. I. Invariant procedures. J. Chem. Phys. 1965; 465: 129–135
   Google Scholar
• Bingham R. C., Dewar M. J. S., Lo D. H. MINDO/3: An improved version of the MINDO semi-empirical SCF-MO method. J. Am. Chem. Soc. 1975; 97: 1285–1293
   Web of Science ®Google Scholar
• Dewar M. J. S., Zoebisch E. G., Healy E. F., Stewart J. J. P. AM1: A new general purpose quantum mechanical molecular model. J. Am. Chem. Soc. 1985; 107: 3902–3909
   Web of Science ®Google Scholar
• Lewis D. F. V. The calculation of molar polarizabilities by the CNDO/2 method: Correlation with the hydrophobic parameter, log P. J. Computat. Chem. 1989; 10: 145–151
   Web of Science ®Google Scholar
• Lewis D. F. V. Molecular orbital calculations on solvents and other small molecules: Correlation between electronic and molecular properties. J. Computat. Chem. 1987; 8: 1084–1089
   Web of Science ®Google Scholar
• Vinter J. G., Davis A., Saunders M. R. Strategic approaches to drug design. I. An integrated software framework for molecular modelling. J. Computer-Aided Mol. Design 1987; 1: 31–51
   PubMedGoogle Scholar
• Jefcoate C. R. E., Graylor J. L., Calabrese R. L. Ligand interactions with cytochrome P450. I. Binding of primary amines. Biochemistry 1969; 8: 3455–3463
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Lake B. G. Molecular modelling of human CYP2B isoforms and their interaction with substrates, inhibitors and redox components. Xenobiotica 1997; 27: 443–487
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Ioannides C., Parks D. V. Molecular modelling of mammalian cytochromes P450 and evaluation of chemical toxicity and metabolism using COMPACT. QSAR and Molecular Modelling: Computational Tools and Biological Applications, F. Sanz, J. Giraldo, F. Manaut. Prous, Barcelona 1996; 595–600
   Google Scholar
• Lewis D. F. V. Cytochromes P450: Structure Function and Mechanisms. Taylor & Francis, London 1996
   Google Scholar
• Ayrton A. D., McFarlane M., Walker R., Neville S., Ioannides C. The induction of P450 I proteins by aromatic amines may be related to their carcinogenic potential. Carcinogenesis 1990; 11: 803–809
   PubMed Web of Science ®Google Scholar
• Ayrton A. D., McFarlane M., Walker R., Neville S., Coombs M. M., Ionnides C. Induction of the P450I family of proteins by polycyclic aromatic hydrocarbons: Possible relationship to their carcinogenicity. Toxicology 1990; 60: 173–186
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V. Quantitative structure–activity relationships in substratesinducers and inhibitors of cytochrome P4501 (CYP1). Drug Metab. Rev. 1997; 29: 589–650
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Ioannides C., Parke D. V., Walker R. Quantitative structure–activity relationships in some cooked food mutagens. Food Addit. Contam. 1995; 12: 715–724
   PubMed Web of Science ®Google Scholar
• Hansch C. Structure–activity relationships of chemical mutagens and carcinogens. QSAR in Environmental Toxicology—IV, J. L. M. Hermens, A. Opperhuizen. Elsevier, Amsterdam 1991; 17–29
   Google Scholar
• Poso A., von Wright A., Gynther J. An empirical and theoretical study on mechanisms of mutagenic activity of hydrazine compounds. Mutat. Res. 1995; 332: 63–71
   PubMed Web of Science ®Google Scholar
• Benigni R., Richard A. M. QSARs of mutagens and carcinogens: Two case studies illustrating problems in the construction of models for noncongeneric chemicals. Mutat. Res. 1996; 371: 29–49
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Pratt J. M. The P450 catalytic cycle and oxygenation mechanism. Drug Metab. Rev. 1998; 30: 739–786
   PubMed Web of Science ®Google Scholar
• Bakale G., McCreary R. D. Response of the ke test to NCI/NTP-screened chemicals. II. Genotoxic carcinogens and non-genotoxic non-carcinogens. Carcinogenesis 1992; 13: 1437–1445
   PubMed Web of Science ®Google Scholar
• Benigni R., Andreoli C., Giuliani A. Structure–activity studies of chemical carcinogenesis: Use of an electrophilic reactivity parameter in a new QSAR model. Carcinogenesis 1989; 10: 55–61
   PubMed Web of Science ®Google Scholar
• Marcus R. A., Sutin N. Electron transfers in chemistry and biology. Biochim. Biophys. Acta 1985; 811: 265–322
   Web of Science ®Google Scholar
• Perring K. D. Application of tritium nuclear magnetic resonance spectroscopy in kinetic and labelling studies, Ph.D. thesis. Department of Chemistry, University of Surrey. 1979
   Google Scholar
• Lewis D. F. V. Cytochromes P450: Structure, Function and Mechanism. Taylor & Francis, London 1996
   Google Scholar
• Jones R. A. Y. Physical and Mechanistic Organic Chemistry. Cambridge University Press, Cambridge 1979
   Google Scholar
• Schofield K. Aromatic Nitration. Cambridge University Press, Cambridge 1980
   Google Scholar
• Lewis D. F. V., Parke D. V. The genotoxicity of benzanthracenes: A quantitative structure–activity study. Mutat. Res. 1995; 328: 207–214
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Ioannides C., Parke D. V. Structural requirements for substrates of cytochromes P450 and P448. Chem.–Biol. Interact. 1987; 64: 39–60
   PubMed Web of Science ®Google Scholar
• Sugden D., Chong N. W. S., Lewis D. F. V. Structural requirements at the melatonin receptor. Br. J. Pharmacol. 1995; 114: 618–623
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Kitchen U., Sugden D., English J., Arendt J. Molecular modelling of G-protein coupled receptors: The interaction between specific ligands and their binding sites. Trends in QSAR and Molecular Modelling, C. G. Wermuth. Elsevier, Amsterdam 1993; 489–494
   Google Scholar
• Lewis D. F. V., Gray T. J. B., Lake B. G. The use of structure–activity relationships. Drug Metabolism from Molecules to Man, D. J. Benford, J. W. Bridges, G. G. Gibson. Taylor & Francis, London 1987; 369–378
   Google Scholar
• Lewis D. F. V. Molecular orbital calculations on tumour inhibitory phenyl aziridines. Xenobiotica 1989; 19: 341–356
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V. Molecular orbital calculations on tumour-inhibitory aniline mustards: QSARs. Xenobiotica 1989; 19: 243–251
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Brantom P. G., Ioannides C., Walker R., Parke D. V. Nitrosamine carcinogenesis: Rodent assays, quantitative structure–activity relationships and human risk assessment. Drug Metab. Rev. 1997; 29: 1055–1078
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Tamburini P. P., Gibson G. G. The interaction of a homologous series of hydrocarbons with hepatic cytochrome P450. Molecular orbital-derived electronic and structural parameters influencing the haemoprotein spin state. Chem.–Biol. Interact. 1986; 58: 289–299
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Lake B. G., Dickins M., Eddershaw P. J., Tarbit M. H., Goldfarb P. S. Molecular modelling of CYP2B6, the human CYP2B isoform, by homology with the substrate-bound CYP102 crystal structure: Evaluation of CYP2B6 substrate binding affinity. Xenobiotica 1999; 29: 361–393
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Ioannides C., Parke D. V. An improved and updated version of the COMPACT procedure for the evaluation of P450-mediated chemical activation. Drug Metab. Rev. 1998; 30: 709–737
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Ioannides C., Parke D. V. Prediction of chemical carcinogenicity from molecular and electronic structures: A comparison of MINDO/3 and CNDO/2 molecular methods. Toxicol. Lett. 1989; 45: 1–13
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Ioannides C., Parke D. V. Molecular modelling of mammalian cytochromes P450 and evaluation of chemical toxicity and metabolism using COMPACT. QSAR and Molecular Modelling: Concepts, Computational Tools and Biological Applications, F. Sanz, J. Giraldo, F. Manaut. Prous, Barcelona 1996; 595–600
   Google Scholar
• Stewart J. J. P. MOPAC: A semi-empirical molecular orbital program. J. Computer-Aided Mol. Design 1990; 4: 1–45
   PubMed Web of Science ®Google Scholar
• Stewart J. J. P. Semi-empirical molecular orbital methods. Rev. Computat. Chem. 1990; 1: 45–81
   Google Scholar
• Sugimura T., Wakabayashi K., Nagao M., Esumi H. A new class of carcinogens: Heterocyclic amines in cooked food. Food, Nutrition and Chemical Toxicity, D. V. Parke, C. Ioannides, R. Walker. Smith-Gordon, London 1993; 259–276
   Google Scholar
• Oesch F., Glatt H., Utesch D. Metabolic perspectives on in vitro tests. Xenobiotica 1988; 18: 35–44
   PubMed Web of Science ®Google Scholar
• Wislocki P. G., Fiorentini K. M., Fu P. P., Yang S. K., Lu A. Y. H. Tumour-initiating ability of the twelve monomethylbenz[a]anthracenes. Carcinogenesis 1982; 3: 215–217
   PubMed Web of Science ®Google Scholar
• Hay R. W. Bio-Inorganic Chemistry. John Wiley & Sons, New York 1984
   Google Scholar
• Lewis D. F. V., Ioannides C., Schulte-Hermann R., Parke D. V. Quantitative structure–activity relationships in a series of endogenous and synthetic steroids exhibiting induction of CYP3A activity and increase in liver weight associated with increased DNA synthesis. J. Steroid Biochem. Mol. Biol., (submitted)
   Google Scholar
• Glennon R. A., Gessner P. K. Serotonin receptor binding affinities of tryptamine analogues. J. Med. Chem. 1979; 22: 428–432
   PubMed Web of Science ®Google Scholar
• Davies R. H., Smith L. H. Partial agonism of cardiac β-adrenoceptor blocking agents and competitive conformer-receptor occupancy. Int. J. Quantum Chem., Quantum Biol. Symp. 1980; 7: 331–345
   Google Scholar
• Pharmacology of Antihypertensive Drugs, A. Scriabine. Raven Press, New York 1980
   Google Scholar
• Michel M. C. β-Adrenergic receptors. Receptor Data for Biological Experiments, H. N. Doods, J. C. A. van Meel. Ellis Horwood, Chichester 1991; 19–22
   Google Scholar
• Safe S., Bandiera S., Sawyer T., Zmudzka B., Mason G., Romkes M., Denomme M. A., Sparling J., Okey A. B., Fujita T. Effects of structure on binding to the 2,3,7,8-TCDD-receptor protein and AHH induction: Halogenated biphenyls. Environ. Health Perspect. 1985; 61: 21–33
   PubMed Web of Science ®Google Scholar
• Denomme M. A., Homonoko K., Fujita T., Sawyer T., Safe S. Effects of substituents on the cytosolic receptor binding avidities and aryl hydrocarbon hydroxylase induction potencies of 7-substituted 2,3-dichlorodibenzo-p-dioxins. Mol. Pharmacol. 1985; 27: 656–661
   PubMed Web of Science ®Google Scholar
• Khan A. H., Ross W. C. J. Tumour-growth inhibitory nitrophenyl aziridines and related compounds: Structure–activity relationship. Chem.–Biol. Interact. 1970; 1: 27–47
   Google Scholar
• Khan A. H., Ross W. C. J. Tumour-growth inhibitory nitrophenyl aziridines and related compounds: Structure–activity relationships. Chem.–Biol. Interact. 1972; 4: 11–22
   Google Scholar
• Bardos T. J., Chmielewicz Z. F., Hebborn P. Structure–activity relationships of alkylating agents in cancer chemotherapy. Ann. NY Acad. Sci. 1968; 163: 1006–1025
   Web of Science ®Google Scholar
• Bardos T. J., Datta-Gupta N., Hebborn P., Tiggle D. J. A study of comparative chemical and biological activities of alkylating agents. J. Med. Chem. 1969; 8: 167–174
   Google Scholar
• Lewis D. F. V. Molecular orbital calculations on tumour-inhibitory phenyl aziridines: QSARs. Xenobiotica 1989; 19: 341–356
   PubMed Web of Science ®Google Scholar
• Wishnok J. S., Archer M. C., Edelman A. S., Rand W. M. Nitrosamine carcinogenicity: A quantitative Hansch–Taft structure–activity relationship. Chem.–Biol. Interact. 1978; 20: 43–54
   PubMed Web of Science ®Google Scholar
• Sangster J. Octanol–water partition coefficients of simple organic compounds. J. Phys. Chem. Ref. Data 1989; 18: 1111–1229
   Web of Science ®Google Scholar
• Suzuki T., Kudo Y. Automatic log P estimation based on combined additive modelling methods. J. Computer-Aided Mol. Design 1990; 4: 155–198
   PubMed Web of Science ®Google Scholar
• White R. E., McCarthy M. Active site mechanics of liver microsomal cytochrome P450. Arch. Biochem. Biophys. 1986; 246: 19–32
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Ioannides C., Parke D. V. A quantitative structure–activity relationship study on a series of 10 para-substituted toluenes binding to cytochrome P4502B4 (CYP2B4) and also their hydroxylation rates. Biochem. Pharmacol. 1995; 50: 619–625
   PubMed Web of Science ®Google Scholar
• Hansch C., Leo A. J. Substituent Constants for Correlation Analysis in Chemistry and Biology. John Wiley & Sons, New York 1979
   Google Scholar
• Eldirdiri N. Uptake and metabolic effects of some halogenoalkanes, Ph.D. Thesis. University of Surrey, GuildfordU.K. 1992
   Google Scholar
• Calleja C., Pascussi J. M., Mani J. C., Maurel P., Vilarem M. J. The antibiotic rifampicin is a nonsteroidal ligand and activator of the human glucocorticoid receptor. Nature Med. 1998; 4: 92–96
   PubMed Web of Science ®Google Scholar
• Kliewer S. A., Moore J. T., Wade L., Staudinger J. L., Watson M. A., Jones S. A., McKee D. D., Oliver B. B., Willson T. M., Zetterstrom R. H., Perlmann T., Lehmann J. M. An orphan nuclear receptor activated by pregnanes defines a novel steroid signalling pathway. Cell 1998; 92: 73–82
   PubMed Web of Science ®Google Scholar
• Lewis D. F. V., Lake B. G. Molecular modelling of the rat peroxisome proliferator-activated receptor α (rPPARα) by homology with the human retinoic acid X receptor α (hRXRα) and investigation of peroxisome proliferator binding interactions: QSARs. Toxicol. In Vitro 1998; 12: 619–632
   PubMed Web of Science ®Google Scholar